Immunexpress Inc.

Seattle, WA Immunexpress Inc.

UEI
KYM8QF1NW567
CAGE
659L3
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
425 Pontius Ave N #470, Seattle, WA 98109, USA
Website
immunexpress.com
Founded
2006
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Immunexpress Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Immunexpress assessment & triage of patients with escalating signs of covid-19 disease using a host response test for… Contract · 75A50120C00125 Office of the Assistant Secretary for Preparedness and Response $749,549

Quick answers

What is Immunexpress Inc.'s UEI?

Immunexpress Inc.'s Unique Entity ID (UEI) in SAM.gov is KYM8QF1NW567.

What is Immunexpress Inc.'s CAGE code?

Immunexpress Inc.'s CAGE code is 659L3.

What is Immunexpress Inc.'s primary NAICS code?

Immunexpress Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Immunexpress Inc. located?

Immunexpress Inc.'s physical address in SAM.gov is 425 Pontius Ave N #470, Seattle, WA 98109, USA.

Is Immunexpress Inc. registered in SAM.gov?

Immunexpress Inc.'s SAM.gov registration expired on September 8, 2026.

What is Immunexpress Inc.'s most recent federal award?

Immunexpress Inc.'s most recent federal contract award is Immunexpress assessment & triage of patients with escalating signs of covid-19 disease using a host response test for… (75A50120C00125), from Office of the Assistant Secretary for Preparedness and Response, on June 11, 2020.

On GovTribe

See Immunexpress Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors